Summit Therapeutics Files 8-K
Ticker: SMMT · Form: 8-K · Filed: May 30, 2025 · CIK: 1599298
| Field | Detail |
|---|---|
| Company | Summit Therapeutics Inc. (SMMT) |
| Form Type | 8-K |
| Filed Date | May 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-k
TL;DR
Summit Therapeutics filed an 8-K, but no juicy details yet.
AI Summary
Summit Therapeutics Inc. filed an 8-K on May 30, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific financial figures or details about the nature of the "Other Events" beyond its classification.
Why It Matters
This 8-K filing indicates a regulatory update from Summit Therapeutics Inc., though the specific details of the 'Other Events' are not disclosed in this summary.
Risk Assessment
Risk Level: low — The filing is a standard 8-K with no immediate negative or positive financial implications disclosed.
Key Players & Entities
- Summit Therapeutics Inc. (company) — Registrant
- May 30, 2025 (date) — Date of Earliest Event Reported
- 001-36866 (company) — Commission File Number
- 37-1979717 (company) — IRS Employer Identification No.
- 601 Brickell Key Drive, Suite 1000 (location) — Principal Executive Offices Address
- Miami, FL 33131 (location) — Principal Executive Offices City, State, Zip
FAQ
What specific event triggered this 8-K filing for Summit Therapeutics Inc. on May 30, 2025?
The filing indicates 'Other Events' and 'Financial Statements and Exhibits' as the items of disclosure, but the specific nature of the 'Other Events' is not detailed in the provided text.
What is the Commission File Number for Summit Therapeutics Inc.?
The Commission File Number for Summit Therapeutics Inc. is 001-36866.
Where are Summit Therapeutics Inc.'s principal executive offices located?
Summit Therapeutics Inc.'s principal executive offices are located at 601 Brickell Key Drive, Suite 1000, Miami, FL 33131.
What is the IRS Employer Identification Number for Summit Therapeutics Inc.?
The IRS Employer Identification Number for Summit Therapeutics Inc. is 37-1979717.
Does this 8-K filing provide any financial results or updates?
The filing lists 'Financial Statements and Exhibits' as an item, but the provided text does not contain specific financial results or updates.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 30, 2025 regarding Summit Therapeutics Inc. (SMMT).